XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Rhea-AI Summary

XOMA Royalty (NASDAQ: XOMA) will report fourth quarter and full year 2025 financial results on Wednesday, March 18, 2026. The company will host a live webcast on March 18, 2026 at 8:00 AM ET to discuss results and provide a business update.

According to the company, the webcast will be accessible on the Investors "News & Events" page and a replay will be available for 30 days after the live event.

News Market Reaction – XOMA

-0.37%

-0.37% Session close to close

In the Mar 12 session, XOMA declined 0.37%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets March 18, 2026 as the date for XOMA Royalty’s Q4 and full-year 2025 results, ...

Analysis

This announcement sets March 18, 2026 as the date for XOMA Royalty’s Q4 and full-year 2025 results, with a webcast at 8:00 am Eastern Time and a 30-day replay. Against a backdrop of recent acquisitions, royalty reshaping, and a CFO transition, these earnings will help clarify how those moves affect profitability, cash, and the royalty portfolio. Investors may focus on integration progress, deal economics, and any updates on future capital deployment.

Key Figures

Earnings date: March 18, 2026 Webcast time: 8:00 am Eastern Time Replay period: 30 days

3 metrics

Earnings date March 18, 2026 Scheduled Q4 and full-year 2025 results release

Webcast time 8:00 am Eastern Time Start time of March 18, 2026 results webcast

Replay period 30 days Duration webcast replay will be available

Historical Context

5 past events · Latest: Feb 18 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 18	Investor conferences	Neutral	+0.2%	Announced executive participation in March 2026 healthcare investor conferences.
Feb 9	M&A completion	Neutral	-4.9%	Closed tender offer and acquisition of Generation Bio with cash and CVR package.
Jan 12	CFO transition	Neutral	-10.3%	Long-tenured CFO stepped down and a new CFO was appointed.
Dec 30	Royalty restructuring	Neutral	+3.7%	Reworked mezagitamab royalty economics and gained rights to nine assets.
Dec 22	Preferred dividends	Positive	+0.8%	Declared quarterly cash dividends on Series A and Series B preferred shares.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent material deals and leadership changes have often seen larger price swings, with acquisitions and the CFO transition followed by notable downside moves, while routine items like conferences and dividends saw smaller, mixed reactions.

Recent Company History

Over the last few months, XOMA Royalty announced investor conference participation on Feb 18, 2026, completed the Generation Bio acquisition on Feb 9, 2026, and executed a CFO transition on Jan 12, 2026. In late 2025, it restructured mezagitamab economics with Takeda on Dec 30, 2025 and declared quarterly preferred dividends on Dec 22, 2025. Against this backdrop of acquisitions, portfolio reshaping, and capital-return actions, the current earnings date announcement serves as a scheduling update ahead of detailed financials.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EMERYVILLE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty announced today it will report fourth quarter and full year 2025 financial results on Wednesday, March 18. The Company will host a webcast on March 18, 2026, at 8:00 am Eastern Time to discuss the results and provide a business update.  

The webcast will be accessible on the “News & Events” page in the Investors section of XOMA Royalty’s website (www.investors.xoma.com/news-events). A replay of the webcast will be available for 30 days following the live event.  

About XOMA Royalty Corporation
XOMA Royalty is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health. XOMA Royalty acquires the potential future economics associated with pre-commercial and commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA Royalty acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance their internal drug candidate(s) or for general corporate purposes. The Company has an extensive and growing portfolio of assets (asset defined as the right to receive potential future economics associated with the advancement of an underlying therapeutic candidate). For more information about the Company and its portfolio, please visit www.xoma.com or follow XOMA Royalty Corporation on LinkedIn.  

Investor contact:	Media contact:
Juliane Snowden	Kathy Vincent
XOMA Royalty Corporation	KV Consulting & Management
+1-646-438-9754	kathy@kathyvincent.com
juliane.snowden@xoma.com

FAQ

When will XOMA (NASDAQ: XOMA) release Q4 and full year 2025 results?

XOMA will release fourth quarter and full year 2025 results on March 18, 2026. According to the company, a webcast discussing the results and a business update will begin at 8:00 AM Eastern Time that same day.

How can investors access XOMA's March 18, 2026 webcast about 2025 results?

Investors can access the live webcast via XOMA's Investors "News & Events" page on its website. According to the company, the webcast link will be posted there and a replay will be available for 30 days after the live event.

What time is XOMA's webcast for the Q4 and full year 2025 results on March 18, 2026?

The webcast is scheduled for 8:00 AM Eastern Time on March 18, 2026. According to the company, management will discuss the financial results and provide a business update during the live presentation and Q&A.

Will XOMA provide a replay of the March 18, 2026 webcast for Q4 and 2025 results?

Yes, XOMA will provide a replay of the March 18, 2026 webcast for 30 days following the live event. According to the company, the replay will be accessible on the Investors "News & Events" page on its website.

Where is XOMA (XOMA) hosting the investor webcast for its 2025 results and business update?

XOMA is hosting the investor webcast on its corporate website under the Investors "News & Events" section. According to the company, the page will include the live link and a replay available for 30 days after the event.